Obstetrics and Gynecology

Journal

Publication Venue For

  • Association of Gestational Diabetes Mellitus With Neonatal Respiratory Morbidity.  133:349-353. 2019
  • Daytime Compared With Nighttime Differences in Management and Outcomes of Postpartum Hemorrhage.  133:155-162. 2019
  • Child Neurodevelopmental Outcomes by Prepregnancy Body Mass Index and Gestational Weight Gain.  132:1386-1393. 2018
  • Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency Syndrome.  132:1112-1115. 2018
  • Association Between Gestational Weight Gain and Perinatal Outcomes.  132:875-881. 2018
  • In Reply..  132:1063. 2018
  • Intrapartum Fetal Heart Rate Tracing Among Small-for-Gestational Age Compared With Appropriate-for-Gestational-Age Neonates.  132:1019-1025. 2018
  • Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.  132:496-505. 2018
  • Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial..  132:20-27. 2018
  • Outpatient Foley Catheter for Induction of Labor in Parous Women: A Randomized Controlled Trial..  132:94-101. 2018
  • In reply.  131:1160-1161. 2018
  • Variation in the nulliparous, term, singleton, vertex cesarean delivery rate.  131:1039-1048. 2018
  • Direct Percutaneous Endoscopic Jejunostomy for the Management of Gastroparesis in Pregnancy..  131:871-874. 2018
  • Perinatal Outcomes in Women With a History of Chronic Hypertension but Normal Blood Pressures Before 20 Weeks of Gestation..  131:827-834. 2018
  • Association of pharmacologic treatment of urgency urinary incontinence with sleep quality and daytime sleepiness.  131:204-211. 2018
  • Pregnancy-associated hypertension and offspring cardiometabolic health.  131:313-321. 2018
  • Institutional protocols for vaginal preparation with antiseptic solution and surgical site infection rate in women undergoing cesarean delivery during labor.  132:371-376. 2018
  • Surgical outcomes after apical repair for vault compared with uterovaginal prolapse.  131:475-483. 2018
  • Surgical Skills Feedback and myTIPreport.  130:17S-23S. 2017
  • The evolution of and evidence for opportunistic salpingectomy.  130:814-824. 2017
  • Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies.  130:511-519. 2017
  • Contraception after Delivery among Publicly Insured Women in Texas.  130:393-402. 2017
  • Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.  130:328-334. 2017
  • Estimating Gestational Age from Ultrasound Fetal Biometrics.  130:433-441. 2017
  • Secnidazole Treatment of Bacterial Vaginosis.  130:379-386. 2017
  • Clinical Validation of a Test for the Diagnosis of Vaginitis.  130:181-189. 2017
  • Characterizing the functional decline of older women with incident urinary incontinence.  130:1025-1032. 2017
  • Maternal and neonatal outcomes in indicated preterm births based on the intended mode of delivery.  130:1143-1151. 2017
  • Modified beef tongue model for fourth-degree laceration repair simulation.  129:491-496. 2017
  • Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer.  129:439-447. 2017
  • Outcomes with cerclage alone compared with cerclage plus 17α-hydroxyprogesterone caproate.  129:390-391. 2017
  • Pregnancies after the diagnosis of mild gestational diabetes mellitus and risk of cardiometabolic disorders.  129:273-280. 2017
  • Racial and ethnic differences in utilization of labor management strategies intended to reduce cesarean delivery rates.  130:1285-1294. 2017
  • Risk factors for postcesarean maternal infection in a trial of extended-spectrum antibiotic prophylaxis.  129:481-485. 2017
  • Readmission and Prolapse Recurrence after Abdominal and Vaginal Apical Suspensions in Older Women.  128:1369-1377. 2016
  • Relationship between Excessive Gestational Weight Gain and Neonatal Adiposity in Women with Mild Gestational Diabetes Mellitus.  128:1325-1332. 2016
  • Maternal and Neonatal Outcomes with Early Compared with Delayed Pushing among Nulliparous Women.  128:1039-1047. 2016
  • Association of Recorded Estimated Fetal Weight and Cesarean Delivery in Attempted Vaginal Delivery at Term.  128:487-494. 2016
  • Baseline renal function tests and adverse outcomes in pregnant patients with chronic hypertension.  128:93-103. 2016
  • Gestational age of delivery in pregnancies complicated by chronic hypertension.  127:1101-1109. 2016
  • Preterm delivery and metabolic syndrome in women followed from prepregnancy through 25 years later.  127:1127-1134. 2016
  • Quality of life and sexual function 2 years after vaginal surgery for prolapse.  127:1071-1079. 2016
  • Carpenter-coustan compared with national diabetes data group criteria for diagnosing gestational diabetes.  127:893-898. 2016
  • Association of the duration of active pushing with obstetric outcomes.  127:667-673. 2016
  • Pregnancy-associated hypertension in glucose-intolerant pregnancy and subsequent metabolic syndrome.  127:771-779. 2016
  • Measures of Maternal Stress and Mood in Relation to Preterm Birth.  127:545-552. 2016
  • Placental Alpha-Microglobulin-1 Test in Resource-Limited Settings: A Cost-Effectiveness Analysis.  127:584-591. 2016
  • Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.  127:289-296. 2016
  • Vaginal Swab Test Compared With the Urethral Q-tip Test for Urethral Mobility Measurement.  127:348-352. 2016
  • A vaginal bowel-control system for the treatment of fecal incontinence.  125:540-547. 2015
  • Assessing white's classification of pregestational diabetes in a contemporary diabetic population.  125:1217-1223. 2015
  • Change in Overactive Bladder Symptoms after Surgery for Stress Urinary Incontinence in Women.  126:423-430. 2015
  • Contraception after delivery and short interpregnancy intervals among women in the United States.  125:1471-1477. 2015
  • Glyburide in Women with Mild Gestational Diabetes: A Randomized Controlled Trial.  126:303-309. 2015
  • In reply.  125:492. 2015
  • Increased cervical cancer risk associated with screening at longer intervals.  125:311-315. 2015
  • Lactation Duration and Midlife Atherosclerosis.  126:381-390. 2015
  • Metabolic Acidemia in Live Births at 35 Weeks of Gestation or Greater.  126:279-283. 2015
  • Morbidly adherent placenta treatments and outcomes.  125:683-689. 2015
  • Nulliparous women in the second stage of labor.  126:81-86. 2015
  • Preparedness of obstetrics and gynecology residents for fellowship training.  126:559-568. 2015
  • Racial and ethnic disparities in maternal morbidity and obstetric care.  125:1460-1467. 2015
  • Second-Trimester Cervical Length Screening Among Asymptomatic Women.  126:61-66. 2015
  • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance.  125:330-337. 2015
  • What is new in stillbirth?: important recent articles.  125:160-161. 2015
  • Frequency of and factors associated with severe maternal morbidity.  123:804-810. 2014
  • Prevalence and trends of symptomatic pelvic floor disorders in U.S. women.  123:141-148. 2014
  • A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery.  123:279-287. 2014
  • Bowel preparation before vaginal prolapse surgery a randomized controlled trial.  123:232-238. 2014
  • Considerations to improve the evidence-based use of vaginal hysterectomy in benign gynecology.  124:585-588. 2014
  • Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.  124:881-885. 2014
  • Foley catheter compared with the controlled-release dinoprostone insert: A randomized controlled trial.  123:1280-1287. 2014
  • Predicting fetal acidemia using umbilical venous cord gas parameters.  124:926-932. 2014
  • Relevance of random biopsy at the transformation zone when colposcopy is negative.  124:670-678. 2014
  • Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation.  123:966-972. 2014
  • Symptom outcomes important to women with anal incontinence: A conceptual framework.  123:1023-1030. 2014
  • The debate on thyroid screening during pregnancy continues.  124:8-9. 2014
  • Trends in hospital volume and patterns of referral for women with gynecologic cancers: adherence to treatment guidelines for ovarian cancer as a measure of quality care..  122:905-906. 2013
  • Decreasing prematurity in twin gestations: predicaments and possibilities..  122:375-379. 2013
  • Vulvar histoplasmosis as a rare cause of genital ulceration.  122:449-452. 2013
  • Activity restriction among women with a short cervix.  121:1181-1186. 2013
  • Erratum: Surgical staples compared with subcuticular suture for skin closure after cesarean delivery: A randomized controlled trial (Obstetrics and Gynecology (2013) 121 (33-8)).  121:1113. 2013
  • In reply:.  121:1108-1109. 2013
  • Patient satisfaction after midurethral sling surgery for stress urinary incontinence.  121:1009-1016. 2013
  • Pregnancy outcomes with weight gain above or below the 2009 institute of medicine guidelines.  121:969-975. 2013
  • 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.  121:829-846. 2013
  • Cesarean delivery for refractory status asthmaticus.  121:417-418. 2013
  • Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.  121:25-31. 2013
  • Hospital variation in postpartum tubal sterilization rates in California and Texas.  121:152-158. 2013
  • In reply.  121:190-191. 2013
  • Surgical staples compared with subcuticular suture for skin closure after cesarean delivery: A randomized controlled trial.  121:33-38. 2013
  • The association of maternal obesity with fetal pH and base deficit at cesarean delivery..  122:262-267. 2013
  • What is new in preterm birth prevention? Important recent articles..  122:390-392. 2013
  • In reply.  120:1209-1210. 2012
  • Perinatal outcomes in hispanic and non-hispanic white women with mild gestational diabetes.  120:1099-1104. 2012
  • Natural history of placenta previa in twins.  120:753-758. 2012
  • The utility of uterine artery doppler velocimetry in prediction of preeclampsia in a low-risk population.  120:815-822. 2012
  • Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women.  119:1227-1233. 2012
  • First-trimester prediction of preeclampsia in nulliparous women at low risk.  119:1234-1242. 2012
  • Normal progress of induced labor.  119:1113-1118. 2012
  • Relationship of subclinical thyroid disease to the incidence of gestational diabetes.  119:983-988. 2012
  • Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling.  119:745-751. 2012
  • Neonatal outcomes after implementation of guidelines limiting elective delivery before 39 weeks of gestation.  119:870. 2012
  • Using a multivariate index assay to assess malignancy in a pelvic mass.  119:365-367. 2012
  • Effect of vaginal lubricants on natural fertility.  120:44-51. 2012
  • Higher-dose oxytocin and hemorrhage after vaginal delivery: A randomized controlled trial.  119:293-300. 2012
  • Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence.  120:91-97. 2012
  • Subclinical thyroid disease and the incidence of hypertension in pregnancy.  119:315-320. 2012
  • Effect of regional anesthesia on the success rate of external cephalic version: A systematic review and meta-analysis.  118:1137-1144. 2011
  • Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment.  118:548-553. 2011
  • Influenza-like illness in hospitalized pregnant and postpartum women during the 2009-2010 H1N1 pandemic.  118:593-600. 2011
  • In reply.  117:1437-1438. 2011
  • Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation.  117:1229. 2011
  • Demographic and clinical predictors of treatment failure one year after midurethral sling surgery.  117:913-921. 2011
  • Effect of antibiotic exposure on nugent score among pregnant women with and without bacterial vaginosis.  117:844-849. 2011
  • Glycemic characteristics and neonatal outcomes of women treated for mild gestational diabetes.  117:819-827. 2011
  • Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: A meta-analysis.  117:663-671. 2011
  • Contraindications to combined oral contraceptives among over-the-counter compared with prescription users..  117:558-565. 2011
  • Reaction to a surgical implant foreign body masquerading as recurrent uterine sarcoma.  117:450-452. 2011
  • In reply.  117:175-176. 2011
  • Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.  117:6-13. 2011
  • The relationship between maternal glycemia and perinatal outcome.  117:218-224. 2011
  • Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes.  117:280-286. 2011
  • Vaginal birth after cesarean for cephalopelvic disproportion: Effect of birth weight difference on success.  117:343-348. 2011
  • Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation.  116:1288-1295. 2010
  • Vitamin C and e supplementation to prevent spontaneous preterm birth: A randomized controlled trial.  116:653-658. 2010
  • Testing and validation of a low-cost cystoscopy teaching model: A randomized controlled trial.  116:85-91. 2010
  • Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: A randomized controlled trial.  115:609-617. 2010
  • Diagnostic dilemmas in a pregnant woman with influenza a (H1N1) infection.  115:409-412. 2010
  • Fetal anomalies in obese women: The contribution of diabetes.  115:290-296. 2010
  • Symptoms of combined prolapse and urinary incontinence in large surgical cohorts.  115:310-316. 2010
  • Improving urinary incontinence in overweight and obese women through modest weight loss.  116:284-292. 2010
  • Pregnancy outcomes in women with thyroid peroxidase antibodies.  116:381-386. 2010
  • Tranexamic acid treatment for heavy menstrual bleeding: A randomized controlled trial.  116:865-875. 2010
  • In reply.  114:1375-1376. 2009
  • Failed operative vaginal delivery.  114:1017-1022. 2009
  • Effects of periodontal therapy on rate of preterm delivery: A randomized controlled trial.  114:551-559. 2009
  • Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions (Obstetrics & Gynecology (2009) 114, (1259-67)).  114:696-697. 2009
  • Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery (Obstetrics and Gynecology (2008) 112, (524-531)).  114:380. 2009
  • Human papillomavirus infection.  114:139-143. 2009
  • In Reply.  114:173-174. 2009
  • Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.  113:1259-1267. 2009
  • Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes.  113:1307-1312. 2009
  • Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial.  113:775-782. 2009
  • Emerging concepts in antibiotic prophylaxis for cesarean delivery: A systematic review.  113:675-682. 2009
  • Preventing excessive weight gain during pregnancy through dietary and lifestyle counseling: A randomized controlled trial.  113:305-312. 2009
  • Effect of weight change on natural history of pelvic organ prolapse.  113:81-88. 2009
  • The frequency and complication rates of hysterectomy accompanying cesarean delivery.  114:224-229. 2009
  • Long-term blood pressure changes measured from before to after pregnancy relative to nonparous women.  112:1294-1302. 2008
  • Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery.  112:524-531. 2008
  • The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: Update on definitions, interpretation, and research guidelines.  112:661-666. 2008
  • Two-year outcomes after surgery for stress urinary incontinence in older compared with younger women.  112:621-629. 2008
  • Two-Year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence.  112:49-55. 2008
  • Lynch syndrome in women less than 50 years of age with endometrial cancer.  111:1161-1166. 2008
  • High costs of urinary incontinence among women electing surgery to treat stress incontinence.  111:899-907. 2008
  • Racial differences in pelvic anatomy by magnetic resonance imaging.  111:914-920. 2008
  • Two decades of the safe motherhood initiative.  111:995. 2008
  • Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis.  111:51-56. 2008
  • Genital tract methicillin-resistant Staphylococcus aureus: Risk of vertical transmission in pregnant women.  111:113-118. 2008
  • Obesity and pelvic floor disorders: A systematic review.  112:341-349. 2008
  • Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women.  110:1034-1040. 2007
  • Perinatal and maternal outcomes in women with sickle or hemoglobin C trait.  110:1113-1119. 2007
  • Two decades of the safe motherhood initiative: Time for another Wooden Spoon Award?.  110:972-976. 2007
  • Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma [15].  110:933-934. 2007
  • Erratum: Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: A randomized controlled trial (Obstetrics and Gynecology (2007) 109, (392-401)).  110:936. 2007
  • Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: A randomized controlled trial.  110:302-309. 2007
  • Correlation of Q-tip values and point Aa in stress-incontinent women.  110:39-43. 2007
  • Anal sphincter laceration at vaginal delivery: Is this event coded accurately?.  109:1141-1145. 2007
  • New advances in vaccine technology and improved cervical cancer prevention.  109:1187-1192. 2007
  • Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy.  109:1129-1135. 2007
  • Natural history of cervical funneling in women at high risk for spontaneous preterm birth.  109:863-869. 2007
  • A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer [14].  109:785-786. 2007
  • Lactation and changes in maternal metabolic risk factors.  109:729-738. 2007
  • Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: A randomized controlled trial.  109:392-401. 2007
  • Magnesium sulfate tocolysis: Time to quit [2].  109:450-451. 2007
  • Oophorectomy in premenopausal women: Health-related quality of life and sexual functioning.  109:347-354. 2007
  • A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer.  108:1375-1379. 2006
  • Cervical intraepithelial neoplasia in adolescent women: Incidence and treatment outcomes.  108:1369-1374. 2006
  • Endoanal ultrasound findings and fecal incontinence symptoms in women with and without recognized anal sphincter tears.  108:1394-1401. 2006
  • Antenatal herpes serologic screening: An appraisal of the evidence.  108:1247-1253. 2006
  • Impact of increased access to emergency contraceptive pills: A randomized controlled trial.  108:1098-1106. 2006
  • Thyroid disease in pregnancy.  108:1283-1292. 2006
  • Fecal and urinary incontinence in primiparous women.  108:863-872. 2006
  • Fetal injury associated with cesarean delivery.  108:885-890. 2006
  • Inflammatory pseudotumor of pelvic lymph nodes.  108:779-782. 2006
  • Synchronous primary endometrial and ovarian carcinoma in a patient with marantic endocarditis..  108:748-750. 2006
  • Association of obesity with pulmonary and nonpulmonary complications of pregnancy in asthmatic women.  108:77-82. 2006
  • Decision-to-incision times and maternal and infant outcomes.  108:6-11. 2006
  • Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery.  108:12-20. 2006
  • Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery.  108:125-133. 2006
  • Impact of anomalous triplets on morbidity outcomes of normal in utero siblings.  107:1352-1356. 2006
  • Risk factors for anal sphincter tear in multiparas.  107:1233-1237. 2006
  • Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes..  107:1139-1146. 2006
  • Effect of coitus on recurrent preterm birth.  107:793-797. 2006
  • The "costs" of urinary incontinence for women.  107:908-916. 2006
  • Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage..  107:493-496. 2006
  • In reply [4].  107:206. 2006
  • Risk of stillbirth following a cesarean delivery: Black-white disparity.  107:383-390. 2006
  • Subclinical hyperthyroidism and pregnancy outcomes.  107:337-341. 2006
  • Subclinical hypothyroidism and pregnancy outcomes [5] (multiple letters).  106:198-199. 2005
  • Sexual functioning after total compared with supracervical hysterectomy: A randomized trial.  105:1309-1318. 2005
  • Pelvic floor surgery in the older woman: Enhanced compared with usual preoperative assessment.  105:800-807. 2005
  • Spontaneous resolution of asymptomatic Chlamydia trachomatis in pregnancy.  105:557-562. 2005
  • Subclinical hypothyroidism and pregnancy outcomes.  105:239-245. 2005
  • Effectiveness of treatment strategies of some women with pelvic inflammatory disease: A randomized trial.  106:573-580. 2005
  • Extreme parity and the risk of stillbirth.  106:446-453. 2005
  • High parity and fetal morbidity outcomes.  105:1045-1051. 2005
  • Pelvic organ prolapse.  106:615-634. 2005
  • Preterm premature rupture of membranes: Is there an optimal gestational age for delivery?.  105:12-17. 2005
  • Stillbirth and infant mortality among Hispanic singletons, twins, and triplets in the United States.  106:789-796. 2005
  • Subcutaneous tissue reapproximation, alone or in combination with drain, in obese women undergoing cesarean delivery.  105:967-973. 2005
  • Thyroid-stimulating hormone in singleton and twin pregnancy: Importance of gestational age-specific reference ranges.  106:753-757. 2005
  • Urinary and anal incontinence in morbidly obese women considering weight loss surgery.  106:1272-1277. 2005
  • Use of vaginal polymorphonuclear to epithelial cell ratios for the prediction of preterm birth.  105:139-144. 2005
  • Validation of referral guidelines for women with pelvic masses..  105:35-41. 2005
  • Early abdominal incision recurrence in a patient with stage i adenocarcinoma of the endometrium.  104:1170-1172. 2004
  • Protrusio acetabuli presenting as a complex pelvic mass after total hip arthroplasty.  104:1187-1189. 2004
  • Bacterial vaginosis and risk of pelvic inflammatory disease.  104:761-769. 2004
  • Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth.  104:777-783. 2004
  • Vulvovaginal symptoms in women with bacterial vaginosis.  104:267-272. 2004
  • Vaginal misoprostol versus concentrated oxytocin and vaginal PGE 2 for second-trimester labor induction.  104:138-145. 2004
  • Erratum: The association of maternal weight with cesarean risk, labor duration, and cervical dilation rate during labor induction (Obstetrics and Gynecology (March 2004) 103 (452-456) DOI: 10.1097/01.AOG.0000125151.53356.03).  103:1019. 2004
  • Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: Clinical outcomes in the medicine or surgery trial.  103:824-833. 2004
  • Resource use for total and supracervical hysterectomies: Results of a randomized trial.  103:834-841. 2004
  • Second-trimester cervical sonography: Features other than cervical length to predict spontaneous preterm birth.  103:457-462. 2004
  • The association of maternal weight with cesarean risk, labor duration, and cervical dilation rate during labor induction.  103:452-456. 2004
  • Asthma during pregnancy.  103:5-12. 2004
  • Childbearing beyond maternal age 50 and fetal outcomes in the United States..  102:1006-1014. 2003
  • Predictors of outcome in the behavioral treatment of urinary incontinence in women..  102:940-947. 2003
  • Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis.  101:1183-1189. 2003
  • Maternal diabetes mellitus and infant malformations [3] (multiple letters).  101:815-816. 2003
  • A randomized comparison of total or supracervical hysterectomy: Surgical complications and clinical outcomes.  102:453-462. 2003
  • Postmenopausal uterine inversion associated with endometrial polyps.  102:521-523. 2003
  • Predictors of outcome in the behavioral treatment of urinary incontinence in women.  102:940-947. 2003
  • Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.  101:847-855. 2003
  • Urinary incontinence in the 12-month postpartum period.  102:1291-1298. 2003
  • Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture.  100:1061-1063. 2002
  • Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture..  100:1061-1063. 2002
  • Uterine leiomyosarcoma metastatic to the thyroid.  100:1122-1124. 2002
  • Uterine leiomyosarcoma metastatic to the thyroid..  100:1122-1124. 2002
  • Do women prefer female obstetricians?.  100:827-828. 2002
  • Do women prefer female obstetricians? [2] (multiple letters).  100:827-828. 2002
  • Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina.  100:765-772. 2002
  • Predicting chlamydial and gonococcal cervical infection: Implications for management of cervicitis.  100:579-584. 2002
  • Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis [3] (multiple letters).  100:380-382. 2002
  • Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.  100:381-382. 2002
  • A randomized trial of intrapartum analgesia in women with severe preeclampsia.  99:452-457. 2002
  • Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.  99:419-425. 2002
  • The efficacy of telecolposcopy compared with traditional colposcopy.  99:248-254. 2002
  • Maternal diabetes mellitus and infant malformations.  100:925-930. 2002
  • The management of preterm labor.  100:1020-1037. 2002
  • Vaginal breech delivery is still justified.  99:1115-1116. 2002
  • Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates.  98:1104-1108. 2001
  • Active phase labor arrest: Revisiting the 2-hour minimum.  98:550-554. 2001
  • Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: A randomized controlled trial.  98:386-390. 2001
  • Seasonality in conception of births and influence on late initiation of prenatal care.  97:976-981. 2001
  • Repeated courses of antenatal corticosteroids.  97:316-317. 2001
  • Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women.  97:225-228. 2001
  • Second-trimester cervical ultrasound: Associations with increased risk for recurrent early spontaneous delivery.  95:222-226. 2000
  • Criteria for failed labor induction: Prospective evaluation of a standardized protocol.  96:671-677. 2000
  • Extra-amniotic saline, laminaria, or prostaglandin E2 gel for labor induction with unfavorable cervix: A randomized controlled trial.  96:106-112. 2000
  • Pregnancy outcomes in healthy nulliparas who developed hypertension.  95:24-28. 2000
  • Ultrasound findings and multiple marker screening in trisomy 18.  95:51-54. 2000
  • Active-phase labor arrest: Oxytocin augmentation for at least 4 hours.  93:323-328. 1999
  • Antibiotic susceptibility profile of group B streptococcus acquired vertically.  92:931-934. 1998
  • Intrauterine viral infection at the time of second trimester genetic amniocentesis.  92:420-424. 1998
  • Pregnancy outcomes following sonographic nonvisualization of the fetal stomach.  91:905-908. 1998
  • Intraoperative hypothermia and post-cesarean wound infection.  91:582-584. 1998
  • Serum leptin concentrations during pregnancy and their relationship to fetal growth.  91:389-395. 1998
  • The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease [1] (multiple letters).  91:156-157. 1998
  • A randomized trial of misoprostol and extra-amniotic saline infusion for cervical ripening and labor induction.  91:774-779. 1998
  • Burkitt lymphoma in pregnancy.  92:675-678. 1998
  • Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population: In reply.  91:239-240. 1998
  • Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population.  90:869-873. 1997
  • Significance of a false-positive trisomy 18 multiple-marker screening test.  90:938-942. 1997
  • Free β-hCG subunit versus intact hCG in Down syndrome screening.  90:370-374. 1997
  • The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease.  90:347-352. 1997
  • Genital herpes during pregnancy: Inability to distinguish primary and recurrent infections clinically.  89:891-895. 1997
  • Detection of genitourinary tract Chlamydia trachomatis infection in pregnant women by ligase chain reaction assay.  89:556-560. 1997
  • Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome..  89:359-363. 1997
  • Gene therapy and ovarian cancer: A review.  89:145-155. 1997
  • One- versus two-layer closure of a low transverse cesarean: The next pregnancy.  89:16-18. 1997
  • Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis..  88:573-576. 1996
  • 24-hour mother-infant discharge with a follow-up home health visit: Results in a selected medicaid population.  88:544-548. 1996
  • Concentrated oxytocin plus low-dose prostaglandin E2compared with prostaglandin E2vaginal suppositories for second-trimester pregnancy termination.  88:110-113. 1996
  • Erratum: Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality (Obstetrics and Gynecology (1995) 85 (1055-1058)).  87:931. 1996
  • Immunoglobulin-containing plasma cells recruited to cervical neoplasia.  87:520-526. 1996
  • Influence of acid-base status at birth and apgar scores on survival in 500–1000-g infants.  87:175-180. 1996
  • Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks' gestation.  88:114-118. 1996
  • Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.  87:213-216. 1996
  • Second-trimester cystic hygroma: Prognosis of septated and nonseptated lesions.  88:979-982. 1996
  • The effect of manual removal of the placenta on post-cesarean endometritis.  87:99-102. 1996
  • Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.  88:573-576. 1996
  • Amnioinfusion survey: prevalence, protocols, and complications..  86:572-576. 1995
  • A new device for collecting cord blood.  86:850-852. 1995
  • Amnioinfusion survey: prevalence, protocols, and complications.  86:572-576. 1995
  • Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum.  85:509-514. 1995
  • Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality.  85:1055-1058. 1995
  • Predicting low apgar scores of infants weighing less than 1000 grams: The effect of corticosteroids.  85:170-174. 1995
  • Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis.  86:868. 1995
  • Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: A cost-effectiveness and cost-benefit analysis.  86:119-123. 1995
  • Subcutaneous tissue approximation in relation to wound disruption after cesarean delivery in obese women.  85:412-416. 1995
  • The Effect of Cigarette Smoking on Neonatal Anthropometric Measurements.  85:625-630. 1995
  • The efficacy of cranial irradiation in ovarian cancer metastatic to the brain: Analysis of 32 cases.  86:955-959. 1995
  • The relationship between maternal and neonatal anthropometric measurements in term newborns.  85:192-196. 1995
  • Active-phase labor arrest: A randomized trial of chorioamnion management.  83:937-940. 1994
  • Amniotic fluid embolism after saline amnioinfusion: Two cases and review of the literature.  83:851-854. 1994
  • Bed rest in pregnancy.  84:131-136. 1994
  • Risk factors for fetal death in white, black, and hispanic women.  84:490-495. 1994
  • Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis.  83:483-494. 1994
  • The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial.  83:609-612. 1994
  • Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.  83:138-141. 1994
  • Anthropometric assessment of body size differences of full-term male and female infants.  81:161-164. 1993
  • Comparison of problem-based and traditional education on student performance in the obstetrics and gynecology clerkship.  82:159-161. 1993
  • Pregnancy outcome following a second-trimester loss.  81:444-446. 1993
  • The Human Genome Project: Implications for the practicing obstetrician.  81:458-462. 1993
  • Serum folate and fetal growth retardation: a matter of compliance?.  79:719-722. 1992
  • Expectant management of preterm ruptured membranes: Effects of antimicrobial therapy.  80:759-762. 1992
  • Recurrence of gestational diabetes mellitus.  80:755-758. 1992
  • Serum folate and fetal growth retardation: A matter of compliance?.  79:719-722. 1992
  • The influence of previous low birth weight on birth weight, gestational age, and anthropometric measurements in the current pregnancy.  79:276-280. 1992
  • The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation.  80:262-267. 1992
  • Black-white differences in newborn anthropometric measurements..  78:782-788. 1991
  • Black-white differences in newborn anthropometric measurements.  78:782-788. 1991
  • Elective hospitalization in the management of twin pregnancies.  77:826-831. 1991
  • Etiologies of preterm birth in an indigent population: Is prevention a logical expectation?.  77:343-347. 1991
  • Maternal serum alpha<inf>2</inf>-macroglobulin and fetal growth retardation.  78:594-599. 1991
  • Mid-second-trimester labor induction: Concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.  77:297-300. 1991
  • Ovarian cancer screening.  77:787-792. 1991
  • The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal and hypertensive patients during active term labor.  77:20-26. 1991
  • The relationship between maternal hematocrit and pregnancy outcome.  77:963. 1991
  • The relationship between maternal hematocrit and pregnancy outcome.  77:190-194. 1991
  • Transvaginal sonography of the endometrium in postmenopausal women.  78:195-199. 1991
  • Uterine contraction pressures achieved in parturients with active phase arrest.  78:344-347. 1991
  • Infant survival following delayed postmortem cesarean delivery..  76:991-992. 1990
  • Early repair of episiotomy dehiscence.  75:48-51. 1990
  • Infant survival following delayed postmortem cesarean delivery.  76:991-992. 1990
  • The alabama preterm birth prevention project.  75:933-939. 1990
  • The effects of epidural anesthesia on the doppler velocimetry of umbilical and uterine arteries in normal term labor.  75:809-812. 1990
  • Sonographic measurements and ratios in fetuses with down syndrome.  74:686. 1989
  • In reply.  74:686. 1989
  • Maternal brain death and prolonged fetal survival.  74:434-437. 1989
  • Sonographic measurements and ratios in fetuses with down syndrome.  73:644-646. 1989
  • Secretory immune system of the female reproductive tract: I. immunoglobulin and secretory component-containing cells.  71:56-60. 1988
  • Effect of type of anesthesia on blood loss at cesarean section.  69:328-332. 1987
  • Fetal deaths in Alabama, 1974-1983: A birth weight-specific analysis.  70:831-835. 1987
  • Hyperandrogenic state associated with a mucinous cystadenoma.  69:507-510. 1987
  • Nuchal cords and neonatal outcome.  70:687-691. 1987
  • Second-stage fetal heart rate abnormalities and type of neonatal acidemia.  70:191-195. 1987
  • The short-term effect of pelvic irradiation for gynecologic malignancies on bladder function.  70:81-84. 1987
  • Twins: Prophylactic hospitalization and ward rest at early gestational age.  69:578-581. 1987
  • Early repair of an external sphincter ani muscle and rectal mucosal dehiscence.  67:806-809. 1986
  • Uterine contraction pressures with oxytocin induction/augmentation.  68:305-309. 1986
  • Survival and Short-term morbidity of the premature neonate.  65:37-41. 1985
  • Term maternal and neonatal complications of acute chorioamnionitis.  66:59-62. 1985
  • A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: A case report and review of the literature.  63:13S-15S. 1984
  • Amylase and isoamylase activities in serum of pregnant women.  63:389-391. 1984
  • Cesarean section: Changing incidence and indications.  63:205-208. 1984
  • Delay in delivery: Influence of gestational age and the duration of delay on perinatal outcome.  64:480-484. 1984
  • Effect of labor on the postpartum bladder.  64:115-118. 1984
  • Neonatal acidosis and method of delivery.  63:681-685. 1984
  • Passive smoking and thiocyanate concentrations in pregnant women and newborns.  63:519-522. 1984
  • Pregnancy and acute optic disc edema of juvenile-onset diabetes.  64:816-818. 1984
  • Second stage fetal heart rate abnormalities and neonatal acidosis.  63:209-213. 1984
  • Ehlers-Danlos syndrome and pregnancy.  61:649-651. 1983
  • Toxemia of pregnancy masquerading as idiopathic thrombocytopenic purpura.  62:32S-34S. 1983
  • Conservative management of patients with premature rupture of fetal membranes.  59:607-610. 1982
  • Squamous cell carcinoma metastatic to placenta and ovary.  59:81S-83S. 1982
  • Plasmapheresis as an adjunct to management of Rh isoimmunization.  57:132-135. 1981
  • Post-Term pregnancy: In reply.  58:135-136. 1981
  • Post-Term pregnancy. I.  56:467-470. 1980
  • Association of extrauterine fetal death with failure of prostaglandin E2 suppositories..  53:56S-58S. 1979
  • Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.  53:56s-58s. 1979
  • A role of fetal prolactin in lung maturation.  51:81-88. 1978
  • Infectious morbidity following cesarean section: Comparison of two treatment regimens.  52:656-661. 1978
  • The bacterial pathogenesis of acute pelvic inflammatory disease.  52:161-164. 1978
  • Takayasu's syndrome in pregnancy..  50:373-375. 1977
  • Early labor initiation with oral PGE<inf>2</inf>after premature rupture of the membranes at term.  49:523-526. 1977
  • Management of pregnancy induced hypertension in the nullipara.  48:253-259. 1976
  • International Standard Serial Number (issn)

  • 0029-7844
  • Electronic International Standard Serial Number (eissn)

  • 1873-233X